-
1by Tao, Wenjing, Santoni, Giola, von Euler-Chelpin, My, Ljung, Rickard, Lynge, Elsebeth, Pukkala, Eero, Ness-Jensen, Eivind, Romundstad, Pål, Tryggvadottir, Laufey, Lagergren, Jesper“...), endometrial cancer (HR 0.69, 95% CI 0.56–0.84) and non-Hodgkin lymphoma (HR 0.64, 95% CI 0.42–0.97) in female...”
Published in Obesity Surgery (2020)
Get access
Get access
Get access
Article in Journal/Newspaper -
2by Tao, Wenjing, Santoni, Giola, von Euler-Chelpin, My, Ljung, Rickard, Lynge, Elsebeth, Pukkala, Eero, Ness-Jensen, Eivind, Romundstad, Pål, Tryggvadottir, Laufey, Lagergren, Jesper“...), endometrial cancer (HR 0.69, 95% CI 0.56–0.84) and non-Hodgkin lymphoma (HR 0.64, 95% CI 0.42–0.97) in female...”
Published in Obesity Surgery (2020)
Get access
Get access
Get access
Article in Journal/Newspaper -
3by Tao, Wenjing, Santoni, Giola, von Euler-Chelpin, My, Ljung, Rickard, Lynge, Elsebeth, Pukkala, Eero, Ness-Jensen, Eivind, Romundstad, Pål, Tryggvadottir, Laufey, Lagergren, Jesper“... decreased risk of breast and endometrial cancer and non-Hodgkin lymphoma in women. Open access funding...”
Published in Obesity Surgery (2020)
Get access
Get access
Article in Journal/Newspaper -
4by Tao, Wenjing, Santoni, Giola, von Euler-Chelpin, My, Ljung, Rickard, Lynge, Elsebeth, Pukkala, Eero, Ness-Jensen, Eivind, Romundstad, Pål, Tryggvadottir, Laufey, Lagergren, Jesper“...), endometrial cancer (HR 0.69, 95% CI 0.56–0.84) and non-Hodgkin lymphoma (HR 0.64, 95% CI 0.42–0.97) in female...”
Published in Obesity Surgery (2020)
Get access
Get access
Get access
Article in Journal/Newspaper